nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge
|
Ferrandina, Gabriella |
|
2007 |
60 |
3 |
p. 459-461 |
artikel |
2 |
A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers
|
Camidge, D. Ross |
|
2006 |
60 |
3 |
p. 391-398 |
artikel |
3 |
Announcement
|
|
|
2007 |
60 |
3 |
p. 463-465 |
artikel |
4 |
Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer
|
Lin, Peng-Chan |
|
2006 |
60 |
3 |
p. 351-356 |
artikel |
5 |
Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
|
Katori, Hideaki |
|
2006 |
60 |
3 |
p. 399-406 |
artikel |
6 |
Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer
|
Fakhrejahani, Elham |
|
2007 |
60 |
3 |
p. 447 |
artikel |
7 |
Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer
|
Fakhrejahani, Elham |
|
2007 |
60 |
3 |
p. 437-446 |
artikel |
8 |
Efficacy of SSG and SSG/IFNα2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action
|
Li, Jing |
|
2006 |
60 |
3 |
p. 341-349 |
artikel |
9 |
Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells
|
Sato, Hiromi |
|
2007 |
60 |
3 |
p. 449-457 |
artikel |
10 |
Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours
|
Bourgeois, H. |
|
2007 |
60 |
3 |
p. 407-413 |
artikel |
11 |
Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPL
|
Fandy, Tamer E. |
|
2006 |
60 |
3 |
p. 313-319 |
artikel |
12 |
Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer
|
Duffour, Jacqueline |
|
2006 |
60 |
3 |
p. 383-389 |
artikel |
13 |
O6-benzylguanine and BCNU in multiple myeloma: a phase II trial
|
Batts, Eric D. |
|
2007 |
60 |
3 |
p. 415-421 |
artikel |
14 |
Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer
|
Hong, Yong Sang |
|
2006 |
60 |
3 |
p. 321-328 |
artikel |
15 |
Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs
|
Verheul, Henk M. W. |
|
2007 |
60 |
3 |
p. 329-339 |
artikel |
16 |
Sunitinib malate
|
Izzedine, Hassane |
|
2006 |
60 |
3 |
p. 357-364 |
artikel |
17 |
The contribution of Gianni Bonadonna to the history of chemotherapy
|
Ribatti, Domenico |
|
2007 |
60 |
3 |
p. 309-312 |
artikel |
18 |
Treatment parameters modulating regression of human melanoma xenografts by an antibody–drug conjugate (CR011-vcMMAE) targeting GPNMB
|
Pollack, Vincent A. |
|
2007 |
60 |
3 |
p. 423-435 |
artikel |
19 |
Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study
|
Brain, E. G. C. |
|
2006 |
60 |
3 |
p. 375-381 |
artikel |
20 |
Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study
|
Bonneterre, J. |
|
2006 |
60 |
3 |
p. 365-373 |
artikel |